Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesOtorhinolaryngology (ENT)Health Net nasal valve repair Coverage Update | Op…
    Ask Trek AI about this page
    CurrentHealth NetPolicy CP.MP.210

    Repair of Nasal Valve Compromise

    Customize your policy alerts

    Sign up for Health Net Policy CP.MP.210 alerts

    Get alerted when Policy CP.MP.210 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical necessity guidelines for surgical and procedural repair of nasal valve compromise for members of Health Net/Centene-affiliated health plans, including which procedures are considered medically necessary versus not medically necessary.

    Policy Summary
    PayerHealth Net
    PolicyRepair of Nasal Valve Compromise
    Policy CodePolicy CP.MP.210
    Change TypeNo material changes
    Effective Date
    Next Review Date
    Key ActionDocument clinical findings, response to the Cottle maneuver or lateralization tests, and prior conservative therapy trials when requesting coverage.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    I. and II.Policy sections

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    1
    Supporting CPT codes
    2Non-supporting CPT codes
    ©2021Year

    Coverage Criteria for Repair of Nasal Valve Compromise

    Medically Necessary Criteria

    Repair of nasal valve compromise is medically necessary when ALL of the following are met:

    Main criteria: Member meets all A–D criteria
    A. Clinical findings: One or more of the following: internal valve collapse or compromise of the upper lateral cartilage; external nasal valve compromise due to collapse of the lower lateral cartilage.

    Clinical findings should be supported by physical examination.

    B. Symptom response to maneuvers: Complaints of obstructed breathing that resolve with the Cottle maneuver or with lateralization of the upper lateral cartilage from inside the nose using an object (e.g., cotton swab, nasal speculum) or demonstrated improvement with outpatient trials of external stents or nasal dilators (e.g., Breathe Right nasal strips, Max-Air Nose Cones, Sinus Cones).
    C. Exclusion of other causes: Other causes of obstructed breathing have been ruled out (examples: sinusitis, allergic or nonallergic rhinitis, nasal polyps, adenoid hypertrophy, nasopharyngeal masses, septal deviation, turbinate hypertrophy).
    D. Conservative therapy trial: Symptoms persist despite conservative treatment such as nasal cones, external nasal dilator adhesive strips, or a six‑week trial of nasal steroids.

    General policy applicability

    Policy scope and application statements:

    Policy governance: This clinical policy is a guide to medical necessity developed by experienced clinicians after review of peer‑reviewed literature and other authoritative sources; it does not constitute a contract or guarantee of payment. Providers must exercise professional medical judgment and consult enrollee coverage documents and applicable state Medicaid or Medicare NCDs/LCDs when applying this policy.

    Coverage decisions are subject to all terms, conditions, exclusions and limitations of the enrollee's coverage documents and to applicable law and plan administrative policies.

    This clinical policy states that certain procedures for repair of nasal valve compromise are not medically necessary because safety and efficacy have not been established. Specifically, the policy identifies radiofrequency ablation (VivAer®), absorbable nasal implants (Latera®), and nasal valve suspension surgery as procedures considered not medically necessary for repairing nasal valve compromise. These exclusions are listed in Section II of the policy and reflect the plan’s assessment of currently available evidence regarding those technologies.

    For Medicaid members/enrollees, when state Medicaid coverage provisions conflict with the coverage provisions in this clinical policy, state Medicaid coverage provisions take precedence. Providers should consult the applicable state Medicaid manual for any coverage provisions that apply to this policy.

    The following procedures are explicitly listed as not medically necessary for the repair of nasal valve compromise: VivAer® (radiofrequency ablation), absorbable nasal implants (Latera®), and nasal valve suspension surgery. The policy cites insufficient established safety and efficacy to support coverage of these specific interventions.

    This document is intended to provide guidance used to evaluate medical necessity and to assist in making coverage decisions, but it does not itself create the legal or contractual definition of medical necessity. Providers are expected to exercise professional medical judgment and to consult enrollee coverage documents and applicable state or federal requirements when applying this guidance.

    Coding — Relevant CPT and Other Codes

    CPT Codes That Support Coverage CriteriaCPTCovered
    30465Repair of nasal vestibular stenosis (e.g., spreader grafting, lateral nasal wall reconstruction)
    CPT Codes That Do Not Support Coverage CriteriaCPTNot Covered
    30468Repair of nasal valve collapse with subcutaneous/submucosal lateral wall implant(s).
    30469Repair of nasal valve collapse with low energy, temperature-controlled (i.e., radiofrequency) subcutaneous/submucosal remodeling
    Referenced codes (document refers to applicable coverage determinations)mixed
    affected codesplaceholder text in this part of the document instructing review of applicable NCDs/LCDs and plan requirements

    Provider Actions, Authorization, and Documentation Requirements

    Prior Authorization

    Prior Authorization / Code Implications

    Prior authorization is required for procedures represented by CPT 30465. Coverage is contingent on documentation that all required clinical criteria (Section I.A–I.D) are met. Verify applicable CPT coding guidance prior to claim submission.

    • Affected code: CPT 30465 (supports coverage)
    • Codes that do not support coverage: CPT 30468, CPT 30469
    Prior Authorization

    Prior Authorization and Coverage Alignment

    Providers must review applicable National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs) prior to applying this policy. Prior authorization requirements and coverage decisions remain subject to the member's contract terms, exclusions, and limitations.

    • Prior authorization applies where the Health Plan requires it
    • Coverage determinations do not guarantee payment and are subject to plan contract terms

    Background

    Nasal valve compromise (NVC), also called nasal valve collapse, is a narrowing of the nasal passage that can cause obstructed breathing. Causes include structural weakness of the internal or external nasal valve (upper lateral cartilage or lower lateral cartilage), prior nasal surgery, trauma, chronic inflammation, congenital defects, or age-related changes. NVC may present as unilateral or bilateral nasal obstruction and is assessed by history, physical examination, maneuvers such as the Cottle test or manual lateralization, and adjunctive objective measures when indicated.

    Definitions and Procedure Summaries

    Internal nasal valve compromise
    DefinitionCollapse or compromise of the upper lateral cartilage leading to obstruction of the internal nasal valve area.
    Clinical finding (policy)Listed as a qualifying clinical finding for medically necessary repair of nasal valve compromise (Section I.A.1).
    Relevant diagnostic maneuversImprovement with Cottle maneuver or lateralization of the upper lateral cartilage helps demonstrate clinical significance.
    External nasal valve compromise
    DefinitionCollapse of the lower lateral cartilage (alar rim) resulting in external nasal valve dysfunction.
    Clinical finding (policy)Listed as a qualifying clinical finding for medically necessary repair of nasal valve compromise (Section I.A.2).
    Policy Summary
    PayerHealth Net
    PolicyRepair of Nasal Valve Compromise
    Policy CodePolicy CP.MP.210
    Change TypeNo material changes
    Effective Date
    Next Review Date
    Key ActionDocument clinical findings, response to the Cottle maneuver or lateralization tests, and prior conservative therapy trials when requesting coverage.
    SourceLink
    On This Page
    Coverage Criteria for Repair of Nasal Valve CompromiseCoding — Relevant CPT and Other CodesProvider Actions, Authorization, and Documentation RequirementsBackgroundDefinitions and Procedure Summaries
    Documentation Required

    Conservative Therapy Requirement

    Conservative therapy must be attempted and documented before surgical intervention. Examples include use of nasal cones, external nasal dilator adhesive strips, or a six-week trial of nasal steroids.

    • Document trials of outpatient nocturnal external stents (e.g., Breathe Right® nasal strips) or nasal dilators (e.g., Max-Air Nose Cones®, Sinus Cones®)
    • Document duration and response to a six-week trial of nasal steroids when used
    Documentation Required

    Required Clinical Documentation

    Document clinical findings supporting nasal valve compromise and response to diagnostic maneuvers. Providers should record physical exam findings (e.g., internal or external valve collapse), results of the Cottle maneuver or lateralization tests, NOSE score when available, and that other causes of obstruction have been ruled out.

    • Document location (unilateral vs bilateral) and duration of symptoms
    • Document exclusion of other causes (sinusitis, allergic/nonallergic rhinitis, nasal polyps, septal deviation, turbinate hypertrophy)
    • Document specific diagnostic tests used and their results (e.g., NOSE score, rhinomanometry, anterior rhinoscopy)
    Denial Risk

    Denial Risk and Applicability

    Procedures that do not meet the specified criteria in Section I or are listed as not medically necessary in Section II (e.g., VivAer® radiofrequency ablation, absorbable implants such as Latera®, nasal valve suspension) are at risk for denial. Providers are expected to exercise professional medical judgment; this policy is guidance and does not guarantee payment.

    • Not medically necessary procedures: CPT 30468, CPT 30469
    • Coverage decisions are subject to enrollee's contract terms and applicable laws
    Related considerationsExternal valve compromise may present with obstructed breathing and should be differentiated from other causes such as septal deviation or turbinate hypertrophy.
    VivAer (Aerin) procedure
    ProcedureOffice-based low-dose radiofrequency (RF) procedure that remodels intranasal soft tissues to reduce nasal valve collapse (Aerin VivAer system).
    Evidence summaryHayes' review cites minimal support; studies are limited in quality and do not clearly demonstrate objective improvements in nasal patency.
    Coverage stanceSpecifically listed as not medically necessary for repair of nasal valve compromise by the Health Plan due to insufficient established safety and efficacy (Section II.A).
    Latera (absorbable implant)
    Device descriptionAbsorbable PLLA/PDLA nasal implant placed endonasally via a 16-gauge cannula to support lateral nasal wall cartilage; envelope by fibrous tissue and absorbed over ~12–18 months with replacement by fibrous collagen matrix.
    Clinical evidenceEvidence is generally very poor quality with limited controlled studies; minimal support for clinical performance compared with other technologies per Hayes review.
    Coverage stanceListed as not medically necessary for repair of nasal valve compromise by the Health Plan because safety and efficacy have not been established (Section II.B).
    Health Plan
    DefinitionA health plan that has adopted this clinical policy and that is operated or administered, in whole or in part, by Centene Management Company, LLC, or affiliates.
    Policy roleThis clinical policy is a guide to medical necessity used to assist coverage decisions and administration of benefits; it does not constitute a contract or guarantee of payment.
    Jurisdictional noteWhere state Medicaid provisions conflict with this clinical policy, state Medicaid coverage provisions take precedence.